| 000 | 01577 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250513192503.0 | ||
| 264 | 0 | _c19990930 | |
| 008 | 199909s 0 0 eng d | ||
| 022 | _a0899-1987 | ||
| 024 | 7 |
_a10.1002/(sici)1098-2744(199909)26:1<20::aid-mc3>3.0.co;2-m _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurnham, M R | |
| 245 | 0 | 0 |
_aThe role of SRC-CAS interactions in cellular transformation: ectopic expression of the carboxy terminus of CAS inhibits SRC-CAS interaction but has no effect on cellular transformation. _h[electronic resource] |
| 260 |
_bMolecular carcinogenesis _cSep 1999 |
||
| 300 |
_a20-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aActins _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Adhesion _xphysiology |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xmetabolism |
| 650 | 0 | 4 |
_aOncogene Protein pp60(v-src) _xgenetics |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-cbl |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aTyrosine _xmetabolism |
| 650 | 0 | 4 | _aUbiquitin-Protein Ligases |
| 650 | 0 | 4 |
_asrc-Family Kinases _xantagonists & inhibitors |
| 700 | 1 | _aHarte, M T | |
| 700 | 1 | _aBouton, A H | |
| 773 | 0 |
_tMolecular carcinogenesis _gvol. 26 _gno. 1 _gp. 20-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(sici)1098-2744(199909)26:1<20::aid-mc3>3.0.co;2-m _zAvailable from publisher's website |
| 999 |
_c10444842 _d10444842 |
||